Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Charuwan Akewanlop"'
Autor:
Thanate Dajsakdipon, Thiti Susiriwatananont, Concord Wongkraisri, Suthinee Ithimakin, Napa Parinyanitikul, Archara Supavavej, Arunee Dechaphunkul, Patrapim Sunpaweravong, Sunee Neesanun, Charuwan Akewanlop, Thitiya Dejthevaporn, TSCO Breast Oncology Group
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background The current standard first-line treatment for hormone receptor-positive/human epidermal growth factor receptor 2 negative (HR + /HER2 −) advanced breast cancer (ABC) is a combination of aromatase inhibitor (AI) plus CDK4/6 inhib
Externí odkaz:
https://doaj.org/article/5b0a3d9bcc4b42bca28dd69de26ddc68
Autor:
Anita Archwamety, Nique Kunapinun, Sirinart Sirinvaravong, Piyaporn Apisarnthanarak, Charuwan Akewanlop, Krittiya Korphaisarn
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Scirrhous hepatocellular carcinoma (S-HCC) represents an uncommon subtype of HCC. During radiological evaluation this unique subtype is frequently mistaken as cholangiocarcinoma, fibrolamellar HCC, or metastatic adenocarcinoma. Here, we present the c
Externí odkaz:
https://doaj.org/article/51a00d5884c24f258189a6e3980d6261
Publikováno v:
Thoracic Cancer, Vol 13, Iss 17, Pp 2539-2541 (2022)
Abstract Here, we report a case of metastatic Epstein–Barr virus (EBV)‐related primary pulmonary lymphoepithelioma‐like carcinoma (PPLELC) in a young, nonsmoking female who responded well to treatment with two types of immune checkpoint inhibit
Externí odkaz:
https://doaj.org/article/278d0beb608a4e0d80c233d4be7f269e
Autor:
Pochamana Phisalprapa, Chayanis Kositamongkol, Krittiya Korphaisarn, Charuwan Akewanlop, Vichien Srimuninnimit, Siripen Supakankunti, Natnasak Apiraksattayakul, Nathorn Chaiyakunapruk
Publikováno v:
Cancers, Vol 15, Iss 20, p 4930 (2023)
This study conducted a cost–utility analysis and a budget impact analysis (BIA) of outpatient oral chemotherapy versus inpatient intravenous chemotherapy for stage III colorectal cancer (CRC) in Thailand. A Markov model was constructed to estimate
Externí odkaz:
https://doaj.org/article/729ca689f4914c44aecfe5814ebb5a41
Autor:
Hope S. Rugo, Eduardo J. Pennella, Unmesh Gopalakrishnan, Miguel Hernandez-Bronchud, Jay Herson, Hans Friedrich Koch, Subramanian Loganathan, Sarika Deodhar, Ashwani Marwah, Alexey Manikhas, Igor Bondarenko, Joseph D. Parra, Maria Luisa T. Abesamis-Tiambeng, Charuwan Akewanlop, Ihor Vynnychenko, Virote Sriuranpong, Sirshendu Roy, Eduardo Patricio Yanez Ruiz, Abhijit Barve, Cornelius F. Waller
Publikováno v:
Breast, Vol 58, Iss , Pp 18-26 (2021)
Background: Trastuzumab-dkst is a biosimilar of trastuzumab. The phase 3 HERITAGE trial demonstrated equivalent overall response rate (ORR) with trastuzumab-dkst or originator trastuzumab at 24 weeks in patients with HER2-positive metastatic breast c
Externí odkaz:
https://doaj.org/article/398ce9856ea34116bdedd35208f23846
Autor:
Jirawat Thanestada MD, Varalak Srinonprasert MD, Akarin Nimmannit MD, Krittiya Korphaisarn MD, Pornpoj Pramyothin MD, Charuwan Akewanlop
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Background: Low muscle mass is associated with worse cancer treatment outcomes. Although dual-energy X-ray absorptiometry or computerized tomography-based analysis have both been widely studied in this clinical setting, studies in the use of bioelect
Externí odkaz:
https://doaj.org/article/79d544b0308d4bb189b8aee39d23b1b9
Autor:
Anita Archwamety, Nattaya Teeyapun, Teerada Siripoon, Naravat Poungvarin, Suebpong Tanasanvimon, Ekaphop Sirachainan, Charuwan Akewanlop, Krittiya Korphaisarn
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundCurrent guidelines recommend anti-epidermal growth factor receptor monoclonal antibodies (anti-EGFR Ab) as first-line treatment only in patients with left-sided RAS wild type (RASwt) metastatic colorectal cancer (mCRC). However, there are n
Externí odkaz:
https://doaj.org/article/f93b82fc8322451c8cf7e1084cfcd615
Autor:
Likit Rugpolmuang, Charuwan Akewanlop, Suchart Benjarassamerote, Pornchai O-chareanrat, Pavanee Mahasitiwat, Apichat Asavamongkolkul
Publikováno v:
Siriraj Medical Journal, Vol 58, Iss 7 (2006)
We present the role of a multidisciplinary approach for the patient with a pathological fracture of the femur. A 56-year-old female complained of pain in the right hip from falling at home. After that she was sent for treatment without knowing her br
Externí odkaz:
https://doaj.org/article/de57910a044d4430a1e3ccb36bf41937
Publikováno v:
Siriraj Medical Journal, Vol 55, Iss 2 (2003)
We report a case of homosexual Thai AIDS patient who presented with mucocutaneous Kaposi's sarcoma (KS) and developed pulmonary involvement which rapidly progressed to a fatal outcome. Although AIDS-KS has been reported as the most common cancer occu
Externí odkaz:
https://doaj.org/article/e27bafc219074de18de08508146e5127
Autor:
Roy S. Herbst, Yi-Long Wu, Thomas John, Christian Grohe, Margarita Majem, Jie Wang, Terufumi Kato, Jonathan W. Goldman, Konstantin Laktionov, Sang-We Kim, Chong-Jen Yu, Huu Vinh Vu, Shun Lu, Kye Young Lee, Guzel Mukhametshina, Charuwan Akewanlop, Filippo de Marinis, Laura Bonanno, Manuel Domine, Frances A. Shepherd, Damien Urban, Xiangning Huang, Ana Bolanos, Marta Stachowiak, Masahiro Tsuboi
Publikováno v:
Journal of Clinical Oncology. 41:1830-1840
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Tr